Eltrombopag
Form: Tablets & Oral suspension
Strength: Tablet: 25 mg, 50 mg, 75 mg; Suspension: 12.5 mg/5 mL
Reference Brands: Promacta® (US & EU); Revolade®(EU)
Category: Hepatitis
Eltrombopag Tablets (Promacta® / Revolade® generic) are thrombopoietin receptor agonists indicated for chronic ITP, severe aplastic anemia, and HCV-related thrombocytopenia. Available in 25 mg, 50 mg, and 75 mg oral tablet strengths, the product is manufactured under EU-GMP and USFDA-compliant facilities. Offered for B2B supply, hospital tenders, and licensing deals, with full CTD dossiers, bioequivalence studies, and regulatory support. Eltrombopag is a key addition for companies supplying hematology and oncology portfolios in regulated and semi-regulated markets, supporting global access to thrombopoiesis-stimulating therapies.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir
Strength: Ombitasvir 12.5 mg / Paritaprevir 75 mg / Ritonavir 50 mg (tablet)+ Dasabuvir 250 mg (tablet)
Form: Tablet
Reference Brands: Viekira Pak® (US); Viekirax® + Exviera® (EU)
View Details Get EnquiryGlecaprevir/Pibrentasvir
Strength: Glecaprevir 100 mg Pibrentasvir 40 mg
Form: Oral tablets
Reference Brands: Mavyret®,
View Details Get Enquiry
Ribavirin
Strength: Tablet:200 mg, 400 mg, 600mg; Capsule:200 mg; Solution:40 mg/mL
Form: Tablets, Capsules and Oral Solution
Reference Brands: Rebetol®, Copegus®, Virazole®(EU & US)
View Details Get Enquiry
Adefovir Dipivoxil
Strength: 10 mg
Form: Oral tablets
Reference Brands: Hepsera® (EU & US)
View Details Get Enquiry